| Literature DB >> 28419259 |
George R Thompson1,2, Janis E Blair3, Sharon Wang2, Robert Bercovitch4, Michael Bolaris5, Dane Van Den Akker6, Rodrigo Lopez7, Arash Heidari8, Antonino Catanzaro4, Jose Cadena7,9, Peter Chin-Hong10, Brad Spellberg11, Royce Johnson8.
Abstract
Coccidioidal meningitis (CM) has high morbidity, and adjunctive measures to improve outcomes are needed. Using an established multicenter retrospective cohort study of CM (N = 221), we found that patients receiving adjunctive corticosteroids had a significant reduction in secondary cerebrovascular events (P = .0049). Those with CM-associated cerebrovascular events (8%) may benefit from short-term corticosteroids.Entities:
Keywords: coccidioidomycosis; corticosteroids; meningitis; stroke; vasculitis
Mesh:
Substances:
Year: 2017 PMID: 28419259 PMCID: PMC5850006 DOI: 10.1093/cid/cix318
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079